1. bookVolumen 5 (2012): Edición 2 (June 2012)
Detalles de la revista
License
Formato
Revista
eISSN
1337-9569
ISSN
1337-6853
Primera edición
19 Jun 2009
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Effect of prenatal administration of venlafaxine on postnatal development of rat offspring

Publicado en línea: 09 Nov 2012
Volumen & Edición: Volumen 5 (2012) - Edición 2 (June 2012)
Páginas: 92 - 97
Detalles de la revista
License
Formato
Revista
eISSN
1337-9569
ISSN
1337-6853
Primera edición
19 Jun 2009
Calendario de la edición
4 veces al año
Idiomas
Inglés

Bellantuono C, Migliarese G, Maggioni F, Imperadore G. (2007) Anridepressant drugs and breastfeeding. Recent Prog Med 98: 29-42.Search in Google Scholar

Chung TK, Lau TK, Yip AS, Chiu HF, Lee DT. (2001). Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63: 830-834.Search in Google Scholar

Da-Silva VA, Alterburg SP, Malheiros LR, Thomaz TG, Lindsey CJ. (1999). Postnatal development of rats exposed to fl uoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res 32: 93-98.Search in Google Scholar

DeSantis DT, Schmaltz LW. (1984). The mother-litter relationship in developmental rat studies: cannibalism vs caring. Dev Psychobiol 17: 255-6210.1002/dev.4201703066539261Search in Google Scholar

Dubovický M, Kovačovský P, Ujházy E, Navarová J, Brucknerová I, Mach M. (2008). Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development Interdiscip Toxicol 1: 206-210.10.2478/v10102-010-0042-y299402421218116Search in Google Scholar

Dubovický M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdiscip Toxicol 3: 59-67.Search in Google Scholar

Evans J, Heron J, Francomb H, Oke S, Golding J. (2001). Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323: 257-260.Search in Google Scholar

Favreliere S, Nourrisson A, Jaafari N, Pérault Pochat MC (2010). Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn. Encephale Suppl 2: D133-D138.Search in Google Scholar

Freeman MP. (2011). Antidepressant medication treatment during pregnancy: prevalence of use, clinical implications, and alternatives. J Clin Psychiatry 72: 977-978.Search in Google Scholar

Gentile S. (2005). SSRIs in pregnancy and lactation: emphasis on neurobehavioral outcome. CNS Drugs 19: 623-633.Search in Google Scholar

Melville JL, Gavin A, Gup Y, Fan MY, Katon WJ. (2010). Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample. Obstet Gynecol. 116: 1064-1070.Search in Google Scholar

Morrison JL, Riggs KW, Rurak DW. (2005). Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 17: 641-650.Search in Google Scholar

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. (2005). Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293: 2372-2383.Search in Google Scholar

Nonacs R, Cohen LS. (2002). Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry 63: 24-30.Search in Google Scholar

Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE. (2010). Prenatal effect of selective serotonin reuptake inhibitor antidepressants, serotonin, transporter promoter genotype (SLC6A4) and maternal mood on child behavior at 3 years of age. Arch Padiatr Adolesc Med 164: 444-451.Search in Google Scholar

OECD. (1995). Guideline for the testing of chemicals, Draft proposal for a new guideline 426, Developmental Neurotoxicity Study.Search in Google Scholar

Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. (2007). Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more eff ective than the selective serotonin reuptake inhibitors in treating major depression disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 62: 1217-1227.Search in Google Scholar

Patil AS, Kuller JA, Rhee EH. (2011) Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 66: 777-8.10.1097/OGX.0b013e31823e0cbf22192462Search in Google Scholar

Pilar-Cuéllar F, Vidal R, Pazos A. (2012). Subchronic treatment with fluoxetine and the 5-HT(2A) antagonist ketanserin upregulates hippocampal BDNF and β-catenin in parallel with antidepressant-like eff ect. Br J Pharmacol. 165(4b): 1046-5710.1111/j.1476-5381.2011.01516.x334624721627639Search in Google Scholar

Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, Kok CH, Coenen A, Froman T. (2009). Placental transfer of SSRI and SNRI antidepressants and eff ects on the neonate. Pharmacopsychiatry 42: 95-100.Search in Google Scholar

Sumner SC, Fennell TR, Snyder RW, Taylor GF, Lewin AH. (2010). Distribution of carbon-14 labeled C60 ([14C]C60) in the pregnant and in the lactating dam and the eff ect of C60 exposure on the biochemical profi le of urine. J Appl Toxicol 30: 354-60.Search in Google Scholar

Tuccori M, Testi A, Antonioli L, Fomai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M. (2009). Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther 31: 1426-1453.Search in Google Scholar

Weikop P, Kehr J, Scheel-Krüger J. (2007). Reciprocal eff ects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors. J. Psychopharmacol. 21: 795-804.Search in Google Scholar

Wellington K, Perry C. (2001). Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs 15: 643-69.Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo